Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(11%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
2
22%
Ph phase_3
1
11%
Ph not_applicable
2
22%
Ph phase_4
3
33%

Phase Distribution

2

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
2(25.0%)
Phase 3Large-scale testing
1(12.5%)
Phase 4Post-market surveillance
3(37.5%)
N/ANon-phased studies
2(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(4)
Other(4)

Detailed Status

unknown4
Completed4
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (25.0%)
Phase 31 (12.5%)
Phase 43 (37.5%)
N/A2 (25.0%)

Trials by Status

unknown444%
active_not_recruiting111%
completed444%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
DRUG
Total Trials
9